1.Lip GY, Laroche C, Dan GA, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservationalResearch Program Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 2014; 16(3): 308-19.2.Kirchhof P, Ammentorp B, Darius H, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events -European Registry in Atrial Fibrillation (PREFER in AF). Europace 2014; 16(1): 6-14.3.Fauchier L, Greenlaw N, Ferrari R, et al. Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry. PLoS One 2015; 10(4): e0125164.4.Bhatia GS, Lip GY. Atrial fibrillation post-myocardial infarction: frequency, consequences, and management. Curr Heart Fail Rep 2004; 1(4): 149-55.5.Schmiegelow MD, Pedersen OD, Køber L, et al. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study. BMC Cardiovasc Disord 2011;11:19.